Melvin K Spigelman's Net Worth
$446 Thousand
Who is Melvin K Spigelman?
Melvin K Spigelman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Synergy Pharmaceuticals, Inc., AN2 Therapeutics, Inc., and MEDICINES CO /DE.
SEC CIK
Melvin K Spigelman's CIK is 0001339901
Past Insider Trading and Trends
2012 was Melvin K Spigelman's most active year for acquiring shares with 5 total transactions. Melvin K Spigelman's most active month to acquire stocks was the month of April. 2018 was Melvin K Spigelman's most active year for disposing of shares, totalling 4 transactions. Melvin K Spigelman's most active month to dispose stocks was the month of April. 2015 saw Melvin K Spigelman paying a total of $417,400.00 for 70,043 shares, this is the most they've acquired in one year. In 2015 Melvin K Spigelman cashed out on 40,000 shares for a total of $810,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Synergy Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 48.3K |
$1.20 | $180,000.00 | 48.3K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AN2 Therapeutics, Inc. (ANTX) Snapshot price: $1.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MEDICINES CO /DE No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$25.25 | -$104,250.00 | 53.13K |
May 25
| |||
Form 4
| +6.49% | 3.24K |
—
|
—
| 53.13K |
May 25
| |||
Form 4
| +17.69% | 7.5K |
$19.60 | $147,000.00 | 49.9K |
May 23
| |||
Form 4
| +8.79% | 3.43K |
—
|
—
| 42.4K |
May 26
| |||
Form 4
|
—
|
0
|
$27.80 | -$276,000.00 | 38.97K |
May 24
| |||
Form 4
|
—
|
0
|
$30.69 | -$392,600.00 | 38.97K |
Aug 31
| |||
Form 4
| +13.16% | 4.53K |
—
|
—
| 38.97K |
May 28
| |||
Form 4
| +15.38% | 4.59K |
—
|
—
| 34.44K |
May 29
| |||
Form 4
| +14.80% | 3.85K |
—
|
—
| 29.85K |
May 30
| |||
Form 4
| +24.32% | 5.09K |
—
|
—
| 26K |
May 22
| |||
Form 4
| +39.43% | 5.91K |
—
|
—
| 20.91K |
May 26
| |||
Form 4
| +33.33% | 3.75K |
—
|
—
| 15K |
Jun 2
| |||
Form 4
| +50.00% | 3.75K |
—
|
—
| 11.25K |
May 28
| |||
Form 4
| +100.00% | 3.75K |
—
|
—
| 7.5K |
May 29
| |||
Form 4
|
∞
| 3.75K |
—
|
—
| 3.75K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |